Literature DB >> 24579826

In vitro and in vivo antitumor activity of Bulbus Fritillariae Cirrhosae and preliminary investigation of its mechanism.

Dong-Dong Wang1, Yong Feng, Zu Li, Li Zhang, Shu Wang, Chao-Yang Zhang, Xiao-Xia Wang, Zi-Yu Liu.   

Abstract

Bulbus Fritillariae Cirrhosae (BFC) is widely used in China both for food and folk medicine because of its powerful biological activities. Firstly, this study was designed to examine the antiproliferative activities of the different fractions from BFC in vitro by MTT assay. The results showed that chloroform extracts (CE) and the purified total alkaloids of BFC (TAF) exhibited stronger antiproliferative activity than the other fractions. We further determined the total alkaloids and 3 main alkaloids monomers content of CE and TAF by UV and HPLC-ELSD methods, respectively. Moreover, we assessed the antitumor activity of TAF in vivo and made preliminary investigation of its antitumor mechanism by histological and immunohistochemical staining technique. These results demonstrate that TAF showed significant antitumor activity and low toxicity in vivo. Meanwhile, TAF significantly inhibited tumor angiogenesis and induced apoptosis by improvement of expression level of caspase-3. These results suggest that alkaloids of BFC could hold a good potential for use as an antitumor drug.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24579826     DOI: 10.1080/01635581.2013.878737

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

Review 1.  A Systematic Review on Traditional Uses, Sources, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Fritillariae Cirrhosae Bulbus.

Authors:  Ting Chen; Furong Zhong; Cheng Yao; Jia Chen; Yiqing Xiang; Jijing Dong; Zhuyun Yan; Yuntong Ma
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-12       Impact factor: 2.629

2.  Evaluation of antitumor property of extracts and steroidal alkaloids from the cultivated Bulbus Fritillariae ussuriensis and preliminary investigation of its mechanism of action.

Authors:  Dongdong Wang; Yun Jiang; Ke Wu; Shu Wang; Yitao Wang
Journal:  BMC Complement Altern Med       Date:  2015-02-21       Impact factor: 3.659

3.  Plant Resource Availability of Medicinal Fritillaria Species in Traditional Producing Regions in Qinghai-Tibet Plateau.

Authors:  Dongdong Wang; Xiong Chen; Atanas G Atanasov; Xiao Yi; Shu Wang
Journal:  Front Pharmacol       Date:  2017-08-07       Impact factor: 5.810

Review 4.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

5.  Metabolite fingerprinting of phytoconstituents from Fritillaria cirrhosa D. Don and molecular docking analysis of bioactive peonidin with microbial drug target proteins.

Authors:  Basharat Ahmad Bhat; Wajahat Rashid Mir; Bashir Ahmad Sheikh; Mustafa Alkanani; Manzoor Ahmad Mir
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

6.  Integrative analysis of the steroidal alkaloids distribution and biosynthesis of bulbs Fritillariae Cirrhosae through metabolome and transcriptome analyses.

Authors:  Qiuxia Lu; Rui Li; Jiaqing Liao; Yuqin Hu; Yundong Gao; Mingcheng Wang; Jian Li; Qi Zhao
Journal:  BMC Genomics       Date:  2022-07-14       Impact factor: 4.547

7.  Optimization of extraction and enrichment of steroidal alkaloids from bulbs of cultivated Fritillaria cirrhosa.

Authors:  Dongdong Wang; Shu Wang; Qingdan Du; Nanyi Wang; Simei Liu; Xiaoxia Wang; Jinghui Jiang
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

8.  The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model.

Authors:  Dongdong Wang; Qingdan Du; Houcong Li; Shu Wang
Journal:  Mediators Inflamm       Date:  2016-07-20       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.